DHG Final 2025 Cash Dividend 50%, Record Date Sept 15

Overview

Dược Hậu Giang (DHG) has announced a record date of September 15, 2026, for its final cash dividend of 50% (5,000 VND per share) for fiscal year 2025. The payment is scheduled for September 30, 2026, with an estimated total payout of VND 653.5 billion. This announcement follows strong first-half 2026 results, with net profit rising 22% year-on-year.

Key Facts

• Record date for the final 2025 cash dividend: September 15, 2026; payment date: September 30, 2026.
• Dividend rate: 50% of par value, equivalent to 5,000 VND per share.
• Total payout estimated at VND 653.5 billion based on 130.7 million outstanding shares.
• Taisho Pharmaceutical Manufacturing Co., Ltd. holds 51.01% (66.7 million shares) and is expected to receive over VND 333 billion.
• SCIC holds 43.31% (56.6 million shares) and is expected to receive about VND 283 billion.
• Combined with the first dividend of 50% paid in May 2026, total 2025 dividends reach 100%.
• H1 2026 revenue: VND 2,561 billion (+8% YoY); net profit: VND 614 billion (+22% YoY); pre-tax profit: VND 706 billion (+25% YoY).
• DHG completed 46% of its 2026 revenue target and 70% of its pre-tax profit target in H1.
• In July 2026, DHG received a tax penalty of over VND 1.6 billion plus back taxes and late payment interest totaling VND 10.4 billion.

What Happened

CTCP Dược Hậu Giang (DHG) announced on its stock exchange filing that it will finalize the shareholder list on September 15, 2026, for the final cash dividend payment for fiscal year 2025. The dividend rate is 50% (5,000 VND per share), with payment to be made on September 30, 2026. This follows an earlier interim dividend of 50% paid in late May 2026, bringing the total 2025 dividend payout to 100%.

The company also disclosed its business results for the first half of 2026. Revenue reached VND 2,561 billion, up 8% year-on-year, while net profit after tax increased 22% to VND 614 billion. Pre-tax profit rose 25% to VND 706 billion. Management attributed the improvement to higher gross profit and effective cost control.

Separately, in July 2026, DHG received a tax penalty decision from the Large Enterprise Tax Office. The company was fined over VND 1.6 billion for two administrative violations: incorrect tax declaration procedures (without underpayment) and incorrect tax base leading to underpaid tax, though the transactions were fully recorded in accounting books. DHG was also required to pay back taxes of over VND 8 billion and late payment interest of over VND 791 million, totaling VND 10.4 billion. DHG stated the violations were common and not tax evasion or fraud, and it would comply with the decision.

Market Context

DHG shares closed at VND 93,300 on August 20, 2026, on the HOSE. The stock has been supported by the company’s consistent dividend policy and resilient earnings growth in the pharmaceutical sector. The H1 2026 results exceeded market expectations, with net profit growth outpacing revenue growth, reflecting improved operational efficiency. The tax penalty, while notable, is relatively small compared to the company’s profitability and is unlikely to materially impact its financial position.

Strategic Significance

DHG’s 100% dividend payout for 2025 underscores its strong cash generation and commitment to shareholder returns, which is a key attraction for income-focused investors. The company’s majority shareholder, Taisho Pharmaceutical, a Japanese firm, provides strategic stability and potential for operational synergies. The H1 2026 performance, achieving 70% of the full-year pre-tax profit target, suggests the company is on track to exceed its annual guidance, supported by cost discipline and a favorable product mix. The tax penalty, while a minor blemish, does not alter the fundamental investment thesis.

What to Watch

• Q3 2026 earnings release (expected October 2026) to see if profit growth momentum continues.
• Any further regulatory or tax-related developments following the July penalty.
• Management’s guidance update for full-year 2026, especially if pre-tax profit target is revised upward.
• Dividend policy for fiscal year 2026, which may be announced in early 2027.
• Foreign ownership trends, as DHG is a large-cap with significant foreign interest.